Abbott Northwestern Hospital (ANW) is part of Allina Health and the largest not-for-profit hospital in the Twin Cities with 600+ beds.  With more than 5,000 employees, 1,400 physicians, and 700 volunteers, ANW has been recognized both nationally and locally for its exceptional expertise and patient care. Awards include but are not limited to:

• Named in 100 Top Hospitals® study by IBM Watson Health™
• S. News & World Report’s Best Hospitals
• Magnet Recognition Status through the American Nurses Credentialing Center (ANCC)
• Four Patient Safety Excellence Awards from the Minnesota Hospital Association since 2008

Pharmacy services at ANW include a variety of clinical and operational practice areas.  Clinical, decentral pharmacist teams include: Behavioral Health/Rehabilitation, Cardiovascular, Critical Care, Emergency Department, Neurology/Orthopedics/Spine, and Renal/Oncology/Medical-Surgical.  Pharmacy operations include sterile product preparation, a surgery pharmacy satellite, an automated medication distribution system through which 90% of doses are supplied, and use of an electronic medical record (Epic). The pharmacy leadership team consists of a director of pharmacy, four managers, six clinical coordinators specializing in infectious diseases, cardiology, oncology and transplant/nephrology, and four lead staff pharmacists specializing in informatics, central operations, sterile products, and surgery.  ANW offers ASHP-accredited residencies in the following areas: PGY1 (5 positions), PGY2 infectious diseases, PGY2 cardiology, and PGY2 health-system administration.

Infectious Diseases Residency Purpose Statement

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

 Residency Overview

The PGY2 infectious diseases pharmacy residency is designed to transition PGY1 residency graduates from general practice to specialized practice focused on the care of patients with infectious diseases. Residency graduates are equipped to participate as integral members of interdisciplinary teams caring for patients with infectious diseases, assuming responsibility for their pharmaceutical care. They are also trained to provide this care as an independent practitioner. The wealth of residency graduates’ knowledge of infectious diseases and their treatment with the anti-infectives class of medications combined with extensive care of individuals with an infectious disease produces a pharmacist who can successfully serve health care organizations as the ultimate resource for information about anti-infectives and for decision making affecting the care of these patients. This includes leadership in formulary decision making for anti-infectives.